StephanieFWilliamsMD
Oncology • Grand Rapids, MIProfessor, Medicine-Hematology/Oncology, Northwestern University Medical School
Dr. Williams is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
145 Michigan St Ne
Suite 5200
Grand Rapids, MI 49503Phone+1 616-486-5933Fax+1 616-486-6489
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1984 - 1987
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1984
Emory University School of MedicineInternship, Internal Medicine, 1981 - 1982
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1981
Certifications & Licensure
IL State Medical License 1983 - 2026
MI State Medical License 2012 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis Start of enrollment: 2012 Apr 01
- Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 4 citationsTeam-Based Care in Oncology: The Impact of the Advanced Practice Provider.Todd Pickard, Stephanie Williams, Eric Tetzlaff, Camille Petraitis, Heather Hylton
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023-06-01 - 16 citationsEffect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder.David E. Fleck, James C. Eliassen, Anna I. Guerdjikova, Nicole Mori, Stephanie Williams
Psychiatry Research. Neuroimaging. 2019-04-30 - 154 citationsAcute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosisRichard A. Larson, Stephanie F. Williams, M M Le Beau, Mitchell A. Bitter, James W. Vardiman
Blood. 1986-12-01
Press Mentions
Waiting for CAR-TJuly 18th, 2019
A New Way to FightJanuary 19th, 2019- Battle in the BodyOctober 8th, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
